-

Shareholder Alert: Robbins LLP is Investigating EBIX, Inc. (EBIX) for Shareholders

SAN DIEGO & JOHNS CREEK, Ga.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating EBIX, Inc. (NASDAQ: EBIX) to determine whether certain Ebix officers and directors violated the Securities Exchange Act of 1934 and breaching their fiduciary duties to the Company. Ebix supplies infrastructure exchanges to the insurance, financial, travel, cash remittances, and healthcare industries.

If you suffered a loss due to Ebix, Inc.'s misconduct, click here.

Ebix, Inc. (EBIX) Misled Shareholders About the Adequacy of its Internal Controls of Financial Reporting

According to a complaint filed against the Company, on February 19, 2021, after the market closed, Ebix revealed that its independent auditor, RSM US LLP, resigned because it was unable "to obtain sufficient appropriate evidence that would allow it to evaluate the business purpose of significant unusual transactions that occurred in the fourth quarter of 2020" related to the Company's business gift card business in India. RSM also stated that the Company's "internal control over financial reporting was not effective as of December 31, 2020 due to the identification of material weaknesses" related to Ebix's failure to design controls "over the gift or prepaid card revenues transaction cycle sufficient to prevent or detect a material misstatement." Further, Ebix and RSM disagreed over the accounting treatment of $30 million that had been transferred into a commingled trust account of Ebix's outside counsel in December 2020. On this news, Ebix shares fell over $20, or approximately 40%, on February 22, 2021.

Ebix, Inc. (EBIX) shareholders have options. If you would like more information regarding your rights, please contact Lauren Levi at (800) 350-6003 or llevi@robbinsllp.com, or via our Shareholder Information Form.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Ebix, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...

PSFE Investor Alert - Paysafe Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Paysafe Limited (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025. Paysafe provides end-to-end payment solutions in the United States and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? March 4, 2025 – November 12, 2025 What...

PMI Investor Alert - Picard Medical, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Picard Medical, Inc. (NYSE: PMI) securities between September 2, 2025 and October 31, 2025. Picard Medical claims to engage in designing, manufacturing, production, supply, marketing, and sale of medical device products. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class...
Back to Newsroom